PLACEBO OF BELIMUMAB, Benlysta 200 mg solution for injection in pre-filled pen.
APHP201098
Phase 3 small_molecule active
Quick answer
PLACEBO OF BELIMUMAB, Benlysta 200 mg solution for injection in pre-filled pen. for Adult patients with persistent or chronic immune thrombocytopenia is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients with persistent or chronic immune thrombocytopenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active